Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
NCT01258205
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Crohn's Disease
Interventions
DRUG:
AMG 139
Sponsor
AstraZeneca